No profile data available.
SeaStar Medical Holding Corporation (ICU) is a healthcare company in the targeted healthcare equipment industry, based in Denver, United States, with about 18 full-time employees.
It reported revenue of $1.23 million for fiscal year 2025, up 814.1% from fiscal year 2024, and net income of -$12.15 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $495,000, up 68.9% from a year before. Its market capitalization was $18.99 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
SeaStar Medical Holding reported $1.23 million in revenue for fiscal year 2025, up 814.1% from $135,000 in fiscal year 2024. In Q1 2026 revenue was $495,000.
$18.99 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Accuray Incorporated (ARAY), Abvc BioPharma, Inc. (ABVC), InspireMD, Inc. (NSPR), Firefly Neuroscience, Inc. (AIFF).